Literature DB >> 25600548

Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.

Hui-Mei An1, Yun-Long Tan1, Jing Shi1, Zhi-Ren Wang1, Jair C Soars2, Jing Qin Wu3, Fu-De Yang1, Xu-Feng Huang4, Xiang Yang Zhang5.   

Abstract

Immune deregulation has been postulated to be one of the mechanisms underlying the pathogenesis of tardive dyskinesia (TD). We hypothesized that interleukins would have a link with TD in schizophrenia patients. In this study, the serum IL-2, IL-6 and IL-8 levels were examined by enzyme-linked immunosorbent assay (ELISA) in schizophrenia patients with TD (n=48) and without TD (n=45), and healthy controls (n=44). The psychopathological symptoms of schizophrenia were assessed by the Positive and Negative Syndrome Scale (PANSS). The severity of TD was evaluated using Abnormal Involuntary Movement Scale (AIMS). The results showed that serum IL-2, IL-6 and IL-8 levels were significantly different among schizophrenia patients with TD and without TD and normal controls. Moreover, IL-2 level was significantly correlated with PANSS positive subscale and general subscale in patients with TD and without TD. In addition, IL-2 level was positively correlated with AIMS score in TD patients. The results supported that immune disturbance is related to the schizophrenia patients, especially to the patients with TD and ILs might play an important role in the pathophysiology of schizophrenia patients with TD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immune; Interleukin; Schizophrenia; Tardive dyskinesia

Mesh:

Substances:

Year:  2015        PMID: 25600548     DOI: 10.1016/j.schres.2014.12.037

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

2.  Association Study of the Complement Component C4 Gene in Tardive Dyskinesia.

Authors:  Clement C Zai; Arun K Tiwari; Gwyneth C Zai; Natalie Freeman; Jennie G Pouget; James Greco; Maria Tampakeras; Sajid A Shaikh; Deanna Herbert; Heather Emmerson; Sheraz Y Cheema; Nicole Braganza; Daniel J Müller; Aristotle N Voineskos; Gary Remington; James L Kennedy
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

3.  The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients.

Authors:  Xue Yang; Hui Zhao; Xuebing Liu; Qin Xie; Xiaoliang Zhou; Qijian Deng; Gang Wang
Journal:  Front Psychiatry       Date:  2020-12-11       Impact factor: 4.157

4.  Correlation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients.

Authors:  Qian Wu; Fengjuan Yuan; Shuo Zhang; Weiting Liu; Qing Miao; Xinhua Zheng; Suxiang Lu; Kaijian Hou
Journal:  Dis Markers       Date:  2022-03-08       Impact factor: 3.434

5.  Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination.

Authors:  Hanzhi Wang; Shubao Liu; Yanping Tian; Xiyan Wu; Yangtao He; Chengren Li; Michael Namaka; Jiming Kong; Hongli Li; Lan Xiao
Journal:  Front Cell Neurosci       Date:  2015-12-21       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.